VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1721933
Sex: F
Age:
State: FL

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: left shoulder is warm at the injection site; left shoulder is a little sore at the injection site; left arm swollen; if she picks up her left arm it's sore; received booster dose; received booster dose; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 99-years-old female patient received third dose of the BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm left on 15 Sep2021 11:00 (at the age of 99 years-old) as dose 3, single for COVID-19 immunization. Medical history included staph infection from 2005 to an unknown date. When probing medical history, she states she had never had anything serious happen to her except one time she had a staph infection that was pretty serious. She had taken a trip and 2-3 weeks after returning home she developed the staph infection. She was really sick. patient had not received any other vaccine within 4 weeks. Patient was not pregnant at time of vaccination. The patient's concomitant medications were not reported. When probing concomitant medications, she states she didn't think her medications are relevant. The patient previously received dose (first and second) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) in right arm on an unknown date in Jan2021 as single dose for COVID-19 immunization. The patient stated that first doses were given in her right arm, and she had no reaction at all from the first 2 doses. She didn't even believe she had the first 2 doses because she felt nothing. Clarified she had no reaction to the first 2 doses. She was calling about the booster shot. She just got her booster dose on Friday 10Sep2021. She reported that today is 15Sep2021, her shoulder is warm and a little sore and it had been sore but today it got very warm at the injection site. It's warm and sore, it's not terrible but she thought she should call. She states she woke up today and her left arm is warm and swollen and if she picks up her left arm it's sore. On 15Sep2021, the patient experienced left shoulder is warm at the injection site, left shoulder is a little sore at the injection site, left arm swollen, if she picks up her left arm it's sore, received booster dose. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was not recovered. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721934
Sex: M
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Tiredness; Ache/ little aching; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: not reported; expiration date: not reported), via an unspecified route of administration on an unspecified date in 2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced tiredness and ache/ little aching that went away the next day. Outcome of the events was reported as recovered in 2021. The lot number for the vaccine was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721935
Sex: F
Age:
State: CO

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Minor itching on cheeks; Sore arm; Headache; This is a spontaneous report from a contactable consumer or other non health professional. This consumer reported for the patient in response to consumer letter. A 82-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL8982, Expiration date not reported), via an unspecified route of administration on 29Jan2021 (at the age of 82 years) as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medication included triamterene, verapamil, levothyroxine, and atorvastatin, all taken for an unspecified indication from an unspecified start date and ongoing. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EK9231, Expiration date not reported), via an unspecified route of administration in right arm on 08Jan2021 (at the age of 82 years) as dose 1, single for covid-19 immunization and experienced reaction in mouth broke out in tiny sores, facial flushing, sore arm, and mild headache. Before vaccination, patient took Benadryl for unspecified indication and was required to wait 40minutes. On an unknown date, the patient experienced minor itching on cheeks, sore arm and mild headache. The nurse recommended treatment with loratadine allergy medication, which patient took before bed, and another one the next evening. The treatment relieved facial itching. The outcome of all the events was unknown.

Other Meds: TRIAMTERENE; VERAPAMIL; LEVOTHYROXINE; ATORVASTATIN

Current Illness:

ID: 1721936
Sex: F
Age:
State: TX

Vax Date: 09/15/2021
Onset Date: 09/15/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Had two headaches, front and back; Stomach ache; Loose stools; Hurt all over; Eyes would not stay open, very very tired; Very scary; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Sep2021 at 00:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included paracetamol (TYLENOL) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received acetylsalicylic acid (ASPIRIN) and experienced drug allergy. On 15Sep2021 at 00:00, the patient felt that the reactions were a lot worse than they should be. On the same day, the patient had two headaches front and back, stomach ache, loose stools, hurt all over, her eyes would not stay open, and was very very tired. She almost went to the emergency room (ER). She would not take the second one. She was very scary. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events had two headaches, front and back, stomach ache, loose stools, hurt all over, eyes would not stay open, very very tired and very scary were resolving at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: TYLENOL

Current Illness:

ID: 1721937
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: could not move his fingers for 2 weeks after the first dose; This is a spontaneous report from a contactable consumer. The consumer reported for a male patient. A male patient of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: was not reported) via an unspecified route of administration, administered anatomical location not reported on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. Reporter stated she received both Pfizer COVID-19 vaccines and will not get the booster dose. Reporter stated that looking at how many had reactions and how many people died, Pfizer did not do so well. Reporter reported that after patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: was not reported) via an unspecified route of administration, administered anatomical location not reported on unspecified date as dose 2, single for COVID-19 immunization patient was sick for 3 weeks. Reporter Caller stated a report that had information about the vaccines stating Pfizer and Moderna, showed that Pfizer had the highest number of reactions, lowest number of reported cases and highest numbers of deaths. Reporter stated this is a withheld report. Reporter stated there were 7000 deaths and it is not over yet. Reporter stated her husband will not get the vaccine because he thinks it is poetic garbage. Reporter stated she got the Pfizer COVID-19 vaccine because of the name and she trusted the name. On unspecified date, after the first bnt162b2 vaccine dose patient could not move his fingers for 2 weeks. The outcome of the event was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721938
Sex: M
Age:
State: FL

Vax Date: 09/09/2021
Onset Date: 09/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: heart pain; mild headache; I do get, sometimes, like a hard beat in my heart so there is some similarity there; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 23-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 09Sep2021 (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was inquiring about additional information regarding side effects of the Pfizer COVID-19 vaccine. On an unspecified date in Sep2021, the patient experienced a mild headache and heart pain. The patient stated that he did get, sometimes, like a hard beat in his heart so there was some similarity there. The patient stated that the heart pain now was rare but it was still there. The patient asked if that was normal. This case was reported as non-serious. The outcome of the event mild headache was unknown. The outcome of the other events was not resolved. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721939
Sex: M
Age:
State:

Vax Date: 02/01/2021
Onset Date: 08/11/2021
Rec V Date: 09/22/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: x-ray; Result Unstructured Data: Test Result:the virus has ravaged his lungs

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; The first dose was last JAN2021 and the second dose was on FEB2021. Last 11AUG2021, her husband started to get sick and got diagnosed with Covid.; This is a spontaneous report from a contactable consumer or other non hcp via a Pfizer-sponsored program. A 66-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on Jan2021 as dose 1, single and second dose via an unspecified route of administration on Feb2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Reporter said that last 11Aug2021, her husband started to get sick and got diagnosed with COVID and has been in the surgical ICU for a month and in a ventilator for 2 weeks. An x-ray showed that the virus has ravaged his lungs and at this point, the doctors said it doesn't look like there's any way he's going to bounce back from this. Reporter also asked that she wanted to know how it's possible that her husband still got sick despite being vaccinated. She also wanted to know if Pfizer can assist in getting a lung transplant. The patient underwent lab tests and procedures which included x-ray: the virus has ravaged his lungs. The outcome of the events was unknown. The lot number for BNT162B2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721940
Sex: F
Age:
State: VA

Vax Date: 09/15/2021
Onset Date: 09/16/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210916; Test Name: Body temperature; Result Unstructured Data: Test Result:100.2; Comments: Low fever 100.2 at 07:30

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Scratchy eyes; Achy; Sore arm; Low fever 100.2; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Sep2021 at 13:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Sep2021 at 07:30, the patient experienced sore arm, low fever 100.2 (unspecified units), achy and scratchy eyes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, low fever 100.2 (unspecified units), achy and scratchy eyes were recovering at the time of report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721941
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Skin rash; This is a spontaneous report from a contactable consumer. A non-pregnant adult female patient (patient's occupation was reported as nurse) of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date, the patient experienced skin rash. The reporter had described a skin rash which was followed up with the dermatologist and questioned about the possible relation to the vaccination. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the event. Since the vaccination, it was unknown whether the patient was tested for COVID-19. The clinical outcome of the event skin rash was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721942
Sex: F
Age:
State: CA

Vax Date: 04/01/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Menstrual cycle time shift to earlier in the month; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date in 2021, the patient's menstrual cycle time shifted to earlier in the month. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle time shift to earlier in the month was unknown at the time of this report.

Other Meds:

Current Illness:

ID: 1721943
Sex: M
Age:
State:

Vax Date: 08/03/2021
Onset Date: 08/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202108; Test Name: covid-19; Test Result: Positive

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: he was diagnosed to have COVID-19; he was diagnosed to have COVID-19; This is a spontaneous report from a contactable other HCP (patient) reported for himself via medical information team. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Aug2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient was unable to get his second dose (scheduled originally on 24Aug2021) due to reasons not health related. The patient medical history and concomitant medications were not reported. In that coming weekend in Aug2021 the patient was diagnosed covid-19 and was currently roughly 17 days out. The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report, a possible causal relationship between reported event Covid 19 and suspect drug BNT162B2 cannot be completely excluded.

Other Meds:

Current Illness:

ID: 1721944
Sex: F
Age:
State:

Vax Date: 08/01/2021
Onset Date: 08/24/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Moderate abdominal cramping about 30 mins following the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (TIROSINT), vitamin D NOS (MANUFACTURER UNKNOWN), prenatal (MANUFACTURER UNKNOWN) and biotin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. On 24Aug2021, about 30 minutes following the vaccine, the patient experienced moderate abdominal cramping, lasting about 30 minutes where the patient had to lay day and it was bad. The moderate abdominal cramping did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event moderate abdominal cramping was resolved an unknown date in Aug2021. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: TIROSINT; VITAMIN D NOS; BIOTIN

Current Illness:

ID: 1721945
Sex: F
Age:
State: PA

Vax Date: 09/05/2021
Onset Date: 09/12/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 05Sep2021 at 11:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 12Sep2021 at 13:00, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with an unspecified medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was resolving at the time of the report.

Other Meds:

Current Illness:

ID: 1721946
Sex: F
Age:
State: OK

Vax Date: 09/16/2021
Onset Date: 09/16/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Tingly feeling in nose (like that of water up the nose); Diminished sense of smell and taste, followed by total loss of smell and taste; Diminished sense of smell and taste, followed by total loss of smell and taste; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Sep2021 at 09:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 16Sep2021 at 17:15, 7-8 hours after injection, the patient experienced tingly feeling in nose (like that of water up the nose) followed by diminished sense of smell and taste, followed by total loss of smell and taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingly feeling in nose (like that of water up the nose) and diminished sense of smell and taste, followed by total loss of smell and taste was not resolved at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721947
Sex: F
Age:
State:

Vax Date: 09/09/2021
Onset Date: 09/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Strange vaginal discharge unlike any period or spotting. Dark in color and at mid cycle; This is a spontaneous report from a non-contactable consumer, the patient. A female patient of an unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Sep2021 at 18:30 as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date in Sep2021, the patient experienced strange vaginal discharge unlike any period or spotting, dark in color and at mid cycle. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event strange vaginal discharge unlike any period or spotting, dark in color and at mid cycle was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721948
Sex: F
Age:
State: IL

Vax Date: 05/26/2021
Onset Date: 05/26/2021
Rec V Date: 09/22/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: She had red blisters and pain; She had red blisters and pain/it was nerve pain; Chest pain; Shingles; Rash scalp, neck and shoulders; It still itches and burns/itching and burning; Her neck was red and rashy; It still itches and burns/neck was itching/itching and burning/her scalph was itching; it is also right across the top of her shoulders and she is pretty sure it is on her scalp because it is itching; This is a spontaneous report from a contactable consumer (patient). A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0183), via an unspecified route of administration on 26May2021 (at the age of 83-year-old), as dose 1, single in left arm for COVID-19 immunization at hospital. The patient's medical history included blood pressure high from 2 years, takes blood pressure by her own and was never normal, 185 over sometimes; had colon cancer two years ago and had surgery but did not take chemo; 20 years ago, she got an autoimmune disorder and lost weight after surgery for colon cancer and has not been able to get over 100 pounds. The patient's past drugs included prednisone; Methotrexate but took them only for a couple of years and had reaction to a codeine product. Concomitant medications included Lisinopril twice daily for two years taken for high blood pressure for two years and Amlodipine added three weeks ago for high blood pressure; start and stop dates were not reported. Patient did not take any other vaccines within 4 weeks after COVID vaccine. On 26May2021, after first dose of vaccine, at night, the patient experienced rash on scalp, neck and shoulders. After vaccination, patient came home and that night after she went to bed, she noticed her neck was itching, she got up and her neck was red and rashy, itching and burning, like a bad sunburn. Patient still had rash four months later. Patient had seen three different doctors; two put her on prednisone; she took two courses of prednisone; and they gave her a prescription for a cream for itching and burning every day. Doctor told her not to get the second dose because she has had a bad reaction and he didn't know what would happen; he doesn't know if it was an allergic reaction. Patient had itches and burns. On an unspecified date in Jun2021, about three weeks or a month after the first dose of the vaccination, she got shingles. Patient never had them before and had to go to the ER to find out why she was in such pain. Doctor explained it was nerve pain. She was in the hospital for about four days from unspecified date in Jun2021 to an unspecified date in Jun2021, for shingles. When she went to the emergency room, she had chest pain and had to admit her to find out exactly what was happening. She was in the hospital about four days but doesn't remember the exact dates. Doctor prescribed prednisone; seven days' supply. She got it and took it exactly as he said and nothing happened, so she called a different doctor who prescribed prednisone again and she took it again. She was also prescribed a cream that did nothing. Now she was doing nothing about it. The doctor at the hospital gave her an antiviral medication for the shingles; she got it twice and it didn't help. Provided the second bottle acyclovir 800mg; one five times daily; prior to that they gave her the same thing, but it was two, three times a day. The shingles are down below the rash a couple of inches, on the right side of her chest and right side of her back and under her right arm and down to the elbow on the right arm. The only cream that kind of helped a little is aspercreme. She can't remember the names of the numbing creams she tried and can't find them. Patient doesn't have any test results from the hospital. The clinical outcome of events shingles; rash scalp, neck and shoulders; it still itches and burns/itching and burning/ her scalp was itching; it is also right across the top of her shoulders and she is pretty sure it is on her scalp because it is itching was not resolved. The clinical outcome of all other events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds: LISINOPRIL; AMLODIPINE

Current Illness:

ID: 1721949
Sex: F
Age:
State: IL

Vax Date: 09/16/2021
Onset Date: 09/17/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Nauseous and throwing up; Nauseous and throwing up; Fever; Legs and arms hurt so badly couldn't lay down; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Sep2021 at 12:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Sep2021 at 02:00, the patient woke up nauseous and throwing up. The patient had a fever and her legs and arms hurt so badly that she couldn't lay down. The patient felt like this for 5 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nauseous and throwing up, fever and legs and arms hurt so badly couldn't lay down was resolving at the time of this report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1721950
Sex: F
Age:
State:

Vax Date: 09/07/2021
Onset Date: 09/08/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Period arrived 11 days late; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Sep2021 at 00:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 08Sep2021, the patient's period arrived 11 days late. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period arrived 11 days late was resolved on an unknown date in Sep2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721951
Sex: F
Age:
State: NY

Vax Date: 08/13/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: After both shots had issues with eyes focusing; Intermittent dizziness; This is a spontaneous report from a contactable nurse, the patient. A 45-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 13Aug2021 at 11:00 (at the age of 45-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3F83) via an unspecified route of administration in the left arm on 14Sep2021 at 11:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS) and attention deficit disorder (ADD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included natalizumab (TYSABRI), methylphenidate hydrochloride (CONCERTA), vitamin d nos (VITAMIN D), levocetirizine dihydrochloride (XYZAL) and fluticasone propionate (FLONASE); all taken for unknown indications from unknown dates and unknown if ongoing. On an unknown date in 2021, after both the shots, the patient had issues with her eyes focusing and intermittent dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events after both shots had issues with eyes focusing and intermittent dizziness was not resolved at the time of the report.

Other Meds: TYSABRI; CONCERTA; VITAMIN D [VITAMIN D NOS]; XYZAL; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1721952
Sex: F
Age:
State: NY

Vax Date: 09/13/2021
Onset Date: 09/14/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Hives all over body; This is a spontaneous report from a contactable healthcare professional, the patient. A 26-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via intramuscular route of administration in the right arm on 13Sep2021 at 14:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 14Sep2021 at 13:00, the patient experienced hives all over body. The event resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hives all over body was not resolved at the time of this report.

Other Meds:

Current Illness:

ID: 1721953
Sex: F
Age:
State: KY

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: little soreness in her arm at the injection site (as for the first dose); This is a spontaneous report from a contactable consumer (patient).A 78-year-old female patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On unknown date, the patient experienced a little soreness in her arm at the injection site. The outcome of the event was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721954
Sex: F
Age:
State: MD

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: back pain; joint pain; I believe it was stress-related; The initial case was missing the following minimum criteria: ICH-Unspecified AE. Upon receipt of follow-up information on 22Mar2021, this case nowcontains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number EL3302 and expiry date not reported), via an unspecified route of administration, on 13Jan2021, as dose 1, single, for COVID-19 immunisation. Medical history included shingles. Concomitant medications included valaciclovir hydrochloride (VALTREX; 500mg daily) taken for shingles, start and stop date were not reported. The patient experienced back pain, joint pain, and stress on an unspecified date in Jan2021. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds: VALTREX.

Current Illness:

ID: 1721955
Sex: F
Age:
State: CA

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: This is a spontaneous report from a contactable consumer reported for herself. A 73-years-old non-pregnant female patient received BNT162B2 (BNT162B2, Pfizer-BioNTech COVID 19 vaccine, Solution for injection, Lot number EN6200) via an unspecified route of administration, administered in Arm Right on 18Feb2021 10:00AM as dose 1, single (age at vaccination 73 years) for COVID-19 immunisation (Other). Medical history included atrial fibrillation, supraventricular tachycardia (SVT), asthma, hypothyroidism, dust and pollen allergy all from an unknown date and unknown if ongoing. Patient was taking other medications in two weeks. Patient was not taken any other vaccines in four weeks. On 18Feb2021 16:00 (04:00 pm) the patient experienced extreme fatigue, some nausea, body aches, overall muscle pain, injection site very sore. Most side effects lasted 3 plus days. No therapeutic measures were taken as result of events. Patient was not having covid prior vaccination and not tested post vaccination. The outcome of the events was recovered on an unknown date in 2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721956
Sex: M
Age:
State:

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: a little bit of a sore arm; This is a spontaneous report from a contactable consumer (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: unknown), dose 1 via an unspecified route of administration on 29Jan2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received second dose of Pfizer-BioNTech COVID-19 Vaccine last Thursday 18Feb2021. The patient reported that first dose was on 29Jan2021, and he had no reactions whatsoever, except for maybe a little bit of a sore arm that lasted for about a day. Patient asked this normal and wanted to know if it is normal or common to not experience side effects after completing the vaccination series. The outcome of event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721957
Sex: F
Age:
State: NE

Vax Date: 01/27/2021
Onset Date: 02/17/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: My arm swelled; My arm swelled and was very sore; I was very tired/felt exhausted; This is a spontaneous report from a contactable other hcp. A 23-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9262), dose 1 via an unspecified route of administration, administered in Arm Left on 27Jan2021 as SINGLE DOSE, dose 2 intramuscular, administered in Arm Left on 17Feb2021 10:00 (Batch/Lot Number: EN6201) as SINGLE DOSE for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient was not pregnant. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive any treatment. Patient was not diagnosed with COVID, prior vaccination. Patient did not receive other vaccine in four weeks of vaccination. Patient has not been tested for COVID, post vaccination. Patient had no known allergies. The patient experienced my arm swelled on 17Feb2021 16:30, my arm swelled and was very sore at 16:30 with outcome of recovered and i was very felt exhausted. The outcome of the events was recovered. Follow-up (13May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721958
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: dizziness; extreme fatigue; diarrhea; nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration on an unspecified date Feb2021 as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. It was reported that, I had prolonged side effects since I received my second shot of the vaccine which was last week Wednesday. On an unspecified date Feb2021, one day and half after receiving the vaccine, the patient experienced diarrhea, nausea, dizziness, and extreme fatigue. Most of my symptoms had resolved except the fatigue, tired more then usual it was getting hard to focus and wanted to know if Pfizer had any recommendations. The clinical outcome of the fatigue was not resolved and rest of the events on an unspecified date Feb2021 was resolved. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721959
Sex: F
Age:
State: OH

Vax Date: 02/06/2021
Onset Date: 02/22/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Extreme Hair Loss; This is a spontaneous report from a contactable consumer (patient, self-reported). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EM9810 STEHS and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 06Feb2021 at 11:45 PM (age at vaccination: 58 years), as a single dose for COVID-19 immunization at school or student health clinic. The patient was not pregnant at the time of vaccination. The patient's medical history included high B/P, high cholesterol, and kidney donor. The patient did not have any known allergies. Concomitant medications included unspecified medications. The patient did not received any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 22Feb2021 at 07:00 AM, the patient experienced extreme hair loss. The patient did not receive any treatment for the event. Outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721960
Sex: F
Age:
State: NJ

Vax Date: 02/11/2021
Onset Date: 02/14/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Underarm swelling; This is a spontaneous report from a contactable consumer (patient). This (age: 74; Unit: Unknown) female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on Thursday, 11Feb2021 09:00 (Batch/Lot Number: EM9809; Expiration Date: 30Jun2021) as DOSE 2, SINGLE for covid-19 immunisation. There were no medical history and concomitant medications. Patient previously took first dose of bnt162b2 (Lot number: EL8982, Expiration Date: 31May2021) administered in Left arm on 21Jan2021 for covid-19 immunisation. It was reported that the patient has had both doses of the COVID Vaccine. After the second dose she started to experience under arm swelling in the arm that she received the vaccine, the left arm. She noticed this around 6PM on 14Feb2021. She confirmed she had no reaction with the first dose. The event did not require Emergency Room and Physician's Office visit. None of the additional vaccines administered on the same date of the Pfizer vaccine considered as suspect. The patient had not received any other vaccine within 4 weeks and did not have any adverse events following prior vaccinations. She questioned if this was a common side effect. Stated she did not see it listed as a common side effect. Outcome of event was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1721961
Sex: F
Age:
State:

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Body aches; This is a spontaneous report from a non-contactable consumer. A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: SN5318) via an unspecified route of administration, administered in Arm Left on 17Feb2021 as DOSE 2, SINGLE (at the age of 39-year-old) for covid-19 immunisation. The patient received the historical vaccine of bnt162b2. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced body aches on 18Feb2021. The patient did not received any treatment for the event. The outcome of the events was recovered on unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1721962
Sex: M
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Throwing up; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration, administered in Arm Right on 24Feb2021 15:00 (at the age of 67-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included cancer, hypertension and diabetes from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient did not receive any other vaccine in 4 weeks prior to the COVID vaccine. Patient did not receive any other medications in 2 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had not been tested for COVID-19. Patient had no known allergies. On 25Feb2021 at 12:00 AM, patient experienced throwing up. There was no treatment for the event. The clinical outcome of event was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721963
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: I was broke out, all over my body; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EL9267, Expiry date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient was trying to report the side effect, the patient was told to do so by emergency room, the Pfizer Covid Shot the patient had on friday and a hour and half later the patient had to go the emergency, the patient was broke out, all over her body and they told the patient to call the hotline and ask if the patient should get the second shot. The adverse event resulted in emergency room visit. Outcome of event was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721964
Sex: F
Age:
State: NY

Vax Date: 02/15/2021
Onset Date: 02/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Diarrhea; Arm uncomfortable; it was sore to the touch and it hurt to move it; Diarrhea was reported as worsened; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 79-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot Number: EL9266; Expiration Date: 31May2021), via an unspecified route of administration, administered in arm left on 15Feb2021 at 12:00 PM (at the age of 79-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced diarrhea was reported as worsened on an unspecified date in Feb2021; arm uncomfortable, it was sore to the touch and it hurt to move it on 15Feb2021; diarrhea on 19Feb2021. Calling about the Covid-19 Vaccine. Stated that she got her 1st dose on 15Feb2021 and for about 1.5 days her arm was uncomfortable; it was sore to the touch and it hurt to move it, but that passed, and now today she has diarrhea. Could that be a side effect of the vaccine. Outcome of the events diarrhea was not recovered; diarrhea was reported as worsened was unknown; it was sore to the touch and it hurt to move it was recovered on an unspecified date in Feb2021; arm uncomfortable was recovered on 16Feb2021. Follow-up (PRD/SRD 13May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721965
Sex: F
Age:
State: NC

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: My vision was fuzzy/One of my co-workers also had this happen to her.; This is a spontaneous report from a contactable other healthcare professional. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 03Feb2021 15:30 (Batch/Lot Number: EL9264) as DOSE 2, SINGLE, dose 1 via an unspecified route of administration, administered in Arm Right on 14Jan2021 14:30 (Batch/Lot Number: EL3248) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included hypertension and concomitant medications were not reported. Known allergies to sulfa drugs, z pak. The patient experienced visual changes, her vision was fuzzy for a few days after receiving first and second dose of vaccine. First dose it was 2 days before vision was back to normal. After second dose, it was on the 4th day when her vision was back to normal. It took about 3-4 days before she was able to focus her vision like normal. She is normally near sighted and wear glasses. Her vision has now returned to normal. One of her co-workers also had this happen to her on an unspecified date with outcome of unknown. Information on the lot batch number has been requested Follow-up (14MAY2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721966
Sex: F
Age:
State: NC

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Under my armpit is swollen and it is a little, like it is sore; Like my lymph node area, that is what it feels like; This is a spontaneous report from a contactable consumer or other non hcp. A 48-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection (Batch/Lot Number: EN8200; Expiration Date: 30Jun2021), via an unspecified route of administration on 17Feb2021 as first dose, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced under my armpit is swollen and it is a little, like it is sore; like my lymph node area, that is what it feels like. The outcome of the event was unknown. Information on lot/ batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721967
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: arm soreness; This is a spontaneous report from a contactable consumer (patient himself). A male patient of an unspecified age received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: not reported; expiration number: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm soreness for about a day, but that was it. The outcome of the event was reported as unknown. Information of lot number was requested. Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021213475 Same reporter/ drug/ event for different patients

Other Meds:

Current Illness:

ID: 1721968
Sex: F
Age:
State:

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Migraine Headache; Vaccine location: Left Leg; This is a spontaneous report from a contactable nurse (patient herself). A 34-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration, in left leg on 20Feb2021 as dose 2, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Historical vaccine included first dose of BNT162B2 via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included migraine from an unspecified date and unknown if ongoing. Patient had no known allergies. Concomitant medication included Excedrin, taken for unspecified indication, start and stop date not reported, taken in two weeks. Other vaccine same date as dose number 2 of Pfizer vaccine, was administered in left arm. On 21Feb2021 12: 00 AM, patient experienced migraine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Treatment was received for the adverse event with Excedrin. The outcome of event was recovering.

Other Meds: EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]

Current Illness:

ID: 1721969
Sex: F
Age:
State: CA

Vax Date: 02/16/2021
Onset Date: 02/19/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Expanding redness on injection site with itching; Expanding redness on injection site with itching; This is a spontaneous report from a contactable consumer (patient). An 81-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EN6301, expiry date: unknown), via an unspecified route of administration, administered in Left arm on 16Feb2021 16:00 PM as DOSE 2, SINGLE for COVID-19 immunisation (age at vaccination: 81-years-old, non-pregnant at the time of vaccination). Medical history included coronary artery disease, hypertension, arthritis, fibromyalgia, hypothyroidism, blood cholesterol abnormal, drug hypersensitivity, and known allergies: sulfa. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EL9262, expiry date: unknown) on 28Jan2021 16:00 PM via unspecified route of administration in left arm as DOSE 1, SINGLE, for covid-19 immunization. She had not received any other vaccines in 4 weeks and, other medicines in two weeks before the vaccination. Not tested covid positive prior or post vaccination. On 19Feb2021, the patient experienced expanding redness on injection site with itching. She did not receive any treatment for the events. Outcome of the events was not recovered. Follow-up attempts are completed. No further information was expected.

Other Meds:

Current Illness:

ID: 1721970
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: cold; This is a spontaneous report from a contactable female consumer (patient) via Pfizer sponsored program. A female patient of unspecified age reported that she received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient wanted to know if the location she got her first dose of the covid vaccine would still be giving the vaccine today due to past week of bad weather. Also wanted to know if patient would be able to take her second dose of the covid vaccine due to her having a cold due to bad weather on an unspecified date. Clarified that the patient did not have any side effects from her first dose of the covid vaccine. Faxing due to having a cold symptom after receiving the first vaccine. Outcome of the event was unknown. Information about lot/Batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1721971
Sex: F
Age:
State: MD

Vax Date: 02/09/2021
Onset Date:
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: unexpected benefit of the Pfizer COVID-19 BNT162b2 vaccine; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient reported for herself). A 73-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9264; Expiration Date: May2021), first dose via an unspecified route of administration on 09Feb2021 (at the age of A 73-year-old) as dose 1, single for COVID-19 immunisation. Medical history included cough from 26Nov2020 to 09Feb2021, sinusitis from an unknown date and unknown if ongoing and always had had sinus issues that resulted in more postnasal drainage. The patient's concomitant medications were not reported. On an unspecified date in 2021, the patient experienced unexpected benefit of the Pfizer covid-19 bnt162b2 vaccine. It was reported that, wanted to let you know there may be a serendipitous benefit to your vaccine that you can make use of to cure upper respiratory conditions. And said this in all seriousness because it cured her. Starting 3 months ago, right around Thanksgiving, she developed a very significant upper respiratory cough. She always had had sinus issues that resulted in more postnasal drainage than most people, and it was around the same time she turned on her house's heating system, and found her whole house humidifier had stopped working, Because of COVID, she did not want HVAC workers in the house, so she figured she should live without the humidifier this winter. The heat was extremely dry, and she assumed that the dryness, plus her chronic sinus issue and intermittent reflux was making her cough a lot. It seemed to come from the throat, and never from the chest. This continued every day from Thanksgiving till 09Feb2021, without any other symptoms. It did not seem to get any better or any worse, but for 2.5 months she was coughing so much on the phone with people that they were always telling her she must have Covid. But she had no other symptoms at all. Then, on 09Feb2021, I had my first Pfizer Covid vaccination, and miraculously, a couple of days later the coughing completely stopped. It did not taper down over several days; it just stopped. It was now 12 days since her shot and her cough has not returned. So, in addition to thanking, you for the vaccine, she wants to add her very sincere gratitude for stopping her cough. she thought you might not know about this benefit, but perhaps there was something in the vaccine that she stumbled on that could be isolated and used to treat coughs or other upper respiratory conditions. She had no symptoms after the shot and was scheduled for the second dose on 02Mar2021 at PRIVACY where she also had the first one. The outcome of the event was reported as unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721972
Sex: F
Age:
State:

Vax Date: 02/20/2021
Onset Date: 02/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Swollen hand and it is the opposite arm; This is a spontaneous report from a contactable consumer (primary consumer-husband and secondary consumer-wife). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: unknown) via an unspecified route of administration on 20feb2021 as single dose for COVID-19 immunization. Medical history, concomitant medications or past drug history of the patient were not reported. On an unspecified date in Feb2021, patient experienced swollen hand and it is the opposite arm. Outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1721973
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Injection site pain; This is a spontaneous report from a non-contactable consumer. This 50-year-old female consumer (patient) reported. A 50-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Right on 24Feb2021 (at the age of 50-years-old) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021, the patient experienced injection site pain. The patient did not receive any treatment. Outcome of the event was not recovered, at the time of this report. No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.

Other Meds:

Current Illness:

ID: 1721974
Sex: F
Age:
State: MA

Vax Date: 02/23/2021
Onset Date: 02/23/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Mild soreness in left are at injection site; This is a spontaneous report from a non-contactable consumer (patient). A 64-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: el3247), via an unspecified route of administration in left arm on 23Feb2021 at 14:15 (at the age of 64-year-old) as dose 1, single for COVID-19 immunisation at workplace clinic. Medical history and concomitant medications were not reported. The patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced mild soreness in left are at injection site on 23Feb2021 at 20:00 with outcome of recovering. The patient did not receive any treatment for the events. The outcome of the event was reported as resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1721975
Sex: M
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/21/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: vaccine reaction; full body rash; hives; itching; This is a spontaneous report from a contactable other hcp (medical assistant calling on behalf of the nurse practitioner). A 35-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported; Expiry Date: unknown) via an unspecified route of administration on 19Feb2021 (at the age of 35-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No investigation assessment was provided. Two days after the second dose of vaccine, on 21Feb2021, the patient began having a full body rash, hives, itching and vaccine reaction. Therapeutic measures were taken as a result of full body rash, hives, itching and vaccine reaction. The patient was placed on 5 days of steroids which were completed on Saturday (27Feb2021) but he was still having a full body rash and was itchy and uncomfortable, the patient received IV famotidine and dexamethasone. The outcome of the events full body rash, hives and itching was not recovered. The outcome of the event vaccine reaction was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1721976
Sex: F
Age:
State: CA

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210305; Test Name: Body temperature; Result Unstructured Data: Test Result:100-101 Fahrenheit; Comments: fever of 100?F-101?F

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: very bad runny nose; fever of 100?F-101?F; This is a spontaneous report from a Pfizer-sponsored program. A contactable 63-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 04Mar2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 05Mar2021, patient began to experience a "very bad runny nose" and a fever of 100 degree F-101 degree F. She reports the symptoms are getting better but still persisting. She was concerned if that was a potential side effect or she needs to get tested for covid. On 05Mar2021, the patient underwent lab tests and procedures which included body temperature resulting 100 degree F-101 degree F. Outcome of the events were recovering/resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1721977
Sex: F
Age:
State: MD

Vax Date: 03/02/2021
Onset Date: 03/04/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: rash on upper back area, behind ears and itching down left arm; rash on upper back area, behind ears and itching down left arm; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 02Mar2021 at 15:30 (Batch/Lot number was not reported; at the age of 54 years old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, prediabetes, and Penicillin allergy. Concomitant medications included fluticasone propionate (FLOVENT HFA) and hydrochlorothiazide. No other vaccine in four weeks. The patient experienced rash on upper back area, behind ears and itching down left arm on 04Mar2021 at 06:30 AM. The patient did not receive treatment for the events. No history of COVID prior to vaccination and has not been tested for COVID post vaccination. The patient is recovering from the events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: FLOVENT HFA; HYDROCHLOROTHIAZIDE.

Current Illness:

ID: 1721978
Sex: M
Age:
State: CA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Face felt tight; Face felt tight, possibly slightly swollen; Slight redness in face; Was exhausted, fatigue; fever; This is a spontaneous report from a contactable consumer (patient, self-reported). A 47-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6198 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 27Feb2021 at 11:00 AM, as a single dose for COVID-19 immunization. The patient's medical history included allergies to pollen, grass, trees, mild allergy to wheat. Concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. On 27Feb2021 at 11:00 AM, the patient experienced face felt tight, possibly slightly swollen, slight redness in face, was exhausted, fatigue and possibly slight fever for 3 days following vaccination. All symptoms subsided after 72 hours. The patient received on sight EMT administered Benadryl as treatment for the events. Outcome of the events was recovered on 02Mar2021 at 11:00. No follow-up attempts are possible; information about lot/batch number cannot be obtaine.

Other Meds:

Current Illness:

ID: 1721979
Sex: F
Age:
State: FL

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Itching all over; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6199), via an unspecified route of administration, administered in left arm on 03Mar2021 11:30 (at the age of 50 years old) as dose 1, single for COVID-19 immunisation. Medical history included asthma and pseudo tumor cerebi. The patient is not pregnant at the time of vaccination. Concomitant medications included azithromycin and prednisone. The patient did not receive other vaccine in four weeks and had no COVID prior to vaccination. The patient experienced itching all over on 03Mar2021 11:30. No treatment was given in response to the event. The patient was not tested for COVID post vaccination. The outcome of the event was recovered on an unspecified date in Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds: AZITHROMYCIN; PREDNISONE

Current Illness:

ID: 1721980
Sex: M
Age:
State: CA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Headache; Some soreness on injection site; Temporary rash on front shoulders; This is a spontaneous report from a contactable healthcare professional (patient). A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration in left arm, on 01Mar2021 at 03:45 PM (15:45) (at the age of 45 years), as dose 1, single, for COVID-19 immunization. The patient's medical history included allergies to certain foods and over the counter (OTC) medications; and antibiotics. The patient's concomitant medications included unspecified antibiotics. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. On 01Mar2021 at 07:15 PM, the patient experienced only a slight headache but very brief, some soreness on injection site for 1 day, and had temporary rash on front shoulders after shower but then it goes away. The patient was not sure if it's related. No treatment was received for the adverse events. The patient had not been tested for COVID-19 post vaccination. The patient recovered from "Some soreness on injection site" on 02Mar2021; and from the remaining events in Mar2021. No follow-up attempts are possible; information about lot or batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1721981
Sex: F
Age:
State: IL

Vax Date: 03/04/2021
Onset Date: 03/06/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: joint pain in left hip; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System. An 86-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration, administered in the left arm on 04Mar2021, at 14:00 (at the age of 86 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies: crab, spinal stenosis, arthritis, and high blood pressure. The patient was not pregnant. Concomitant medications included quinapril, amlodipine, and tramadol. She did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Mar2021, at 16:00, the patient experienced joint pain in left hip. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the event. The patient was recovering from joint pain in left hip. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: QUINAPRIL; AMLODIPINE; TRAMADOL

Current Illness:

ID: 1721982
Sex: F
Age:
State: FL

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 09/22/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chills; Bad headache; Rash on her armpits and back of her neck; Lethargic; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9269), via an unspecified route of administration in left arm, on 10Feb2021 at 01:45 PM (13:45) (at the age of 69 years), as dose 2, single, for COVID-19 immunization. The patient's medical history included rheumatoid and osteoarthritis. The patient's concomitant medications included unspecified medications. The patient previously received the first dose of BNT162B2 (Lot Number: EL9262) on 20Jan2021 at 10:45 AM (at the age of 69 years) for COVID-19 immunization with no reaction at all (right arm). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The most recent vaccine was administered in a public health clinic or Veterans administration facility. On 11Feb2021 at 01:00 AM, the patient experienced 4 to 5 hours of chills during the night with a bad headache. On the next morning (11Feb2021), the patient had a rash on her armpits and back of her neck (chills and headache were gone) and she was lethargic all day. The patient went to work the next day. The patient was administered with the vaccine on a Wednesday (10Feb2021) and she was back to work on Friday (12Feb2021). No treatment was received for the adverse events. The patient had not been tested for COVID-19 post vaccination. The patient recovered from "Chills" and "Bad headache" on 11Feb2021 (unspecified time); and from the remaining events in Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am